Consequently, we evaluated a panel of well-known breast cancer markers BRCA1, BRCA2, BRIP1, CHEK2, PALB2, RB1 [21], and TP53 [22], for predictive accuracy in lung cancer. This evidence concerns the gene CHEK2 and breast carcinoma.